Citation: | Please cite this article as: LYU SX, QIAN DF, FENG YF, SHEN CW, GUO LB, LYU JT, JIN PF, LI T, TAN SY, ZHANG ZX, HUANG L, ZHONG X, SU LQ, HU X, HUANG X, CUI XY. Safety of butylphthalide and edaravone in patients with ischemic stroke: a multicenter real-world study. J Geriatr Cardiol 2023; 20(4): 293−308. DOI: 10.26599/1671-5411.2023.04.002 |
[1] |
Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation 2020; 141: e139−e596. doi: 10.1161/CIR.0000000000000757
|
[2] |
Wu S, Wu B, Liu M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol 2019; 18: 394−405. doi: 10.1016/S1474-4422(18)30500-3
|
[3] |
Peng B, Wu B. [Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018]. Chin J Neurol 2018; 51: 666−682. [In Chinese]. doi: 10.3760/cma.j.issn.1006-7876.2018.09.004
|
[4] |
Wang S, Ma F, Huang L, et al. Dl-3-n-butylphthalide (NBP): a promising therapeutic agent for ischemic stroke. CNS Neurol Disord Drug Targets 2018; 17: 338−347. doi: 10.2174/1871527317666180612125843
|
[5] |
Watanabe K, Tanaka M, Yuki S, et al. How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis? J Clin Biochem Nutr 2018; 62: 20−38. doi: 10.3164/jcbn.17-62
|
[6] |
Ren Y, Wei B, Song X, et al. Edaravone’s free radical scavenging mechanisms of neuroprotection against cerebral ischemia: review of the literature. Int J Neurosci 2015; 125: 555−565. doi: 10.3109/00207454.2014.959121
|
[7] |
Chen C, Li M, Lin L, et al. Clinical effects and safety of edaravone in treatment of acute ischaemic stroke: a meta-analysis of randomized controlled trials. J Clin Pharm Ther 2021; 46: 907−917. doi: 10.1111/jcpt.13392
|
[8] |
Public Policy Committee, International Society of Pharmacoepidemiology. Guidelines for good pharmacoepidemiology practice (GPP). Pharmacoepidemiol Drug Saf 2016; 25: 2−10. doi: 10.1002/pds.3891
|
[9] |
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013; 310: 2191−2194. doi: 10.1001/jama.2013.281053
|
[10] |
Tian J, Lei P, He Y, et al. Absorption, distribution, metabolism, and excretion of [14C]NBP (3-n-butylphthalide) in rats. J Chromatogr B Analyt Technol Biomed Life Sci 2021; 1181: 122915. doi: 10.1016/j.jchromb.2021.122915
|
[11] |
Ma L, Sun J, Peng Y, et al. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform. Drug Metab Dispos 2012; 40: 734−741. doi: 10.1124/dmd.111.043356
|
[12] |
Petri H, de Vet HC, Naus J, et al. Prescription sequence analysis: a new and fast method for assessing certain adverse reactions of prescription drugs in large populations. Stat Med 1988; 7: 1171−1175. doi: 10.1002/sim.4780071110
|
[13] |
Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology 1996; 7: 478−484. doi: 10.1097/00001648-199609000-00005
|
[14] |
Tsiropoulos I, Andersen M, Hallas J. Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. Pharmacoepidemiol Drug Saf 2009; 18: 483−491. doi: 10.1002/pds.1736
|
[15] |
Wahab IA, Pratt NL, Ellett LK, et al. Sequence symmetry analysis as a signal detection tool for potential heart failure adverse events in an administrative claims database. Drug Saf 2016; 39: 347−354. doi: 10.1007/s40264-015-0391-8
|
[16] |
Pratt N, Andersen M, Bergman U, et al. Multi-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study. Pharmacoepidemiol Drug Saf 2013; 22: 915−924. doi: 10.1002/pds.3440
|
[17] |
Roughead EE, Chan EW, Choi NK, et al. Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis. Expert Opin Drug Saf 2016; 15: 1589−1595. doi: 10.1080/14740338.2016.1238071
|